GR3018244T3 - Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae. - Google Patents

Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae.

Info

Publication number
GR3018244T3
GR3018244T3 GR950403365T GR950403365T GR3018244T3 GR 3018244 T3 GR3018244 T3 GR 3018244T3 GR 950403365 T GR950403365 T GR 950403365T GR 950403365 T GR950403365 T GR 950403365T GR 3018244 T3 GR3018244 T3 GR 3018244T3
Authority
GR
Greece
Prior art keywords
pct
mycobacterium chelonae
drug based
glycopeptidolipids
polar
Prior art date
Application number
GR950403365T
Other languages
Greek (el)
English (en)
Inventor
Tsehay Neway
Charles Pilet
Original Assignee
Tsehay Neway
Charles Pilet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsehay Neway, Charles Pilet filed Critical Tsehay Neway
Publication of GR3018244T3 publication Critical patent/GR3018244T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR950403365T 1990-06-06 1995-11-29 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae. GR3018244T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006997A FR2662942B1 (fr) 1990-06-06 1990-06-06 Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
PCT/FR1991/000449 WO1991018617A1 (fr) 1990-06-06 1991-06-06 Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae

Publications (1)

Publication Number Publication Date
GR3018244T3 true GR3018244T3 (en) 1996-02-29

Family

ID=9397303

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950403365T GR3018244T3 (en) 1990-06-06 1995-11-29 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae.

Country Status (12)

Country Link
US (1) US5336666A (da)
EP (1) EP0485577B1 (da)
JP (1) JP2709979B2 (da)
AT (1) ATE127021T1 (da)
AU (1) AU655425B2 (da)
CA (1) CA2063721C (da)
DE (1) DE69112573T2 (da)
DK (1) DK0485577T3 (da)
ES (1) ES2080320T3 (da)
FR (1) FR2662942B1 (da)
GR (1) GR3018244T3 (da)
WO (1) WO1991018617A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE179333T1 (de) * 1993-01-29 1999-05-15 Vetrepharm Inc Immunotherapeutische zubereitung
CA2170142C (en) * 1993-08-27 2010-05-25 Jose M. Wade Composition and method for stimulation of reproductive performance
JP2001519785A (ja) * 1997-04-02 2001-10-23 バイオニケ ライフ サイエンシーズ インコーポレイテッド 局所的障害および創傷の治療のための細菌細胞壁抽出物の使用
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
GB9822619D0 (en) * 1998-10-19 1998-12-09 Porter William L Immune response stimulation
HUP0202537A3 (en) * 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
AU2002353366A1 (en) * 2001-12-10 2003-06-23 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物

Also Published As

Publication number Publication date
US5336666A (en) 1994-08-09
FR2662942B1 (fr) 1992-09-18
WO1991018617A1 (fr) 1991-12-12
AU8090591A (en) 1991-12-31
ATE127021T1 (de) 1995-09-15
CA2063721A1 (fr) 1991-12-07
JP2709979B2 (ja) 1998-02-04
ES2080320T3 (es) 1996-02-01
EP0485577B1 (fr) 1995-08-30
JPH05500817A (ja) 1993-02-18
DK0485577T3 (da) 1996-01-15
DE69112573T2 (de) 1996-04-25
AU655425B2 (en) 1994-12-22
DE69112573D1 (de) 1995-10-05
CA2063721C (fr) 1998-10-27
EP0485577A1 (fr) 1992-05-20
FR2662942A1 (fr) 1991-12-13

Similar Documents

Publication Publication Date Title
EP0784471A4 (en) FACET-FITTED METHOD FOR SUPPRESSING THE REPRODUCTION OF LATEN VIRUSES IN HUMANS AND ANIMALS
MX9205046A (es) 1h-imidazo-(4,5-c)quinolin-4-aminas 1-substituidas
NO952321L (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
WO1987003480A3 (fr) Medicament a effet anti-tumoral contenant de l'hexadecylphosphocholine
PT702560E (pt) Intensificacao imunologica com terapia intermitente de interleucina-2
GR3032037T3 (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
GR3018244T3 (en) Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae.
DE68918944D1 (de) Künstliche rezeptor-analoge.
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
AU1439588A (en) Synergistic immunostimulating compositions and method
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
PT100891A (pt) Per-hidro-1h-pirido {1,2-a} pirazinas 2-substituidas neurolepticas
ES8607728A1 (es) Procedimiento de preparacion de una nueva composicion anti- biotica sinergetica, de uso veterinario
CA2170142A1 (en) Composition and method for stimulation of reproductive performance
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
NO874241D0 (no) Terapeutisk aktive salter.
HU9202026D0 (en) Method and medical preparative for treatment of thrombocytopenie
HK1006540A1 (en) Thyroxine in restoring neuronal plasticity
PT695303E (pt) Sais de piridinio e seu emprego no combate as bacterias helicobacter
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
AU2133895A (en) Electronic control and triggering member set in the mouth, in particular for physically disabled persons
ATE221068T1 (de) Anellierte beta-carboline